Specificity", "sentences": [], "annotations": [], "relations": []}, {"offset": 25335, "infons": {"section_type": "METHODS", "type": "paragraph"}, "text": "The specificity of the method of NA assay was verified by comparing the chromatograms of the contaminant-free samples (finished and prolonged dosage form products) before and after spiking with the corresponding analytes. No peaks from the tablet matrix should coelute at the retention times of any of the NAs.", "sentences": [], "annotations": [], "relations": []}, {"offset": 25646, "infons": {"section_type": "METHODS", "type": "title_3"}, "text": "4.5.2. Linearity, Precision and Accuracy, Limits of Detection (LOD) and Limits of Quantification (LOQ)", "sentences": [], "annotations": [], "relations": []}, {"offset": 25749, "infons": {"section_type": "METHODS", "type": "paragraph"}, "text": "Analytes were quantified using d6-NDMA as IS for all NAs. For the determination of linearity of the NDMA, NDEA, NDPA, NDBA NPip, Npyr, and Nmor assay three eight-point calibration curves were constructed as described in Section 4.3. The calibration curves were evaluated individually by linear regression. The slopes, intercepts, and the coefficients of determination of the corresponding individual curves were calculated. For acceptable linearity, the coefficient of determination of each calibration curve should be R2 >= 0.995.", "sentences": [], "annotations": [], "relations": []}, {"offset": 26282, "infons": {"section_type": "METHODS", "type": "paragraph"}, "text": "The acceptable accuracy of six injections of three different concentration, including 1.5 ng/mL, 2.0 ng/mL, and 2.5 ng/mL, expressed as the percentage of the measured concentration versus the theoretical concentration of the prepared solutions, should be in a range between 90-110%. The precision, expressed as the relative standard deviation, should not exceed 15% at each concentration level tested.", "sentences": [], "annotations": [], "relations": []}, {"offset": 26686, "infons": {"section_type": "METHODS", "type": "paragraph"}, "text": "LODs and LOQs were calculated using the linearity curves based on the standard deviation of the response (sigma) and the slope of the curves (S) using the multiplier suggested by the ICH standard. The LOD and LOQ were calculated from the following equations: LOD = (3.3 x sigma/S) and LOD = (10 x sigma/S).", "sentences": [], "annotations": [], "relations": []}, {"offset": 26993, "infons": {"section_type": "METHODS", "type": "title_3"}, "text": "4.5.3. Recovery", "sentences": [], "annotations": [], "relations": []}, {"offset": 27009, "infons": {"section_type": "METHODS", "type": "paragraph"}, "text": "In each metformin sample analysis, the spike solution was prepared by spiking NAs solution to an obtained a final concentration of 2.0 ng/mL NAs in the organic phase. The recovery was calculated as the ratio of subtracted mean results of the sample from the calculated result of the spiked solution, to the theoretical spiking concentration. Additionally, the recovery of the IS was calculated as a ratio of the mean IS peak area in the sample solution to the mean IS peak area in the standard solution.", "sentences": [], "annotations": [], "relations": []}, {"offset": 27513, "infons": {"section_type": "METHODS", "type": "title_3"}, "text": "4.5.4. System Suitability Test", "sentences": [], "annotations": [], "relations": []}, {"offset": 27544, "infons": {"section_type": "METHODS", "type": "paragraph"}, "text": "To validate each test, the listed conditions have to be met: No interfering signals in the sample blank solution; no significant co-elution in the spiked sample solutions; S/N of the spiked test solutions has to be at least 10 for all spiked NAs signals; correlation of the calibration curves has to be at least 0.995; area of d6-NDMA in the sample solution has to be at least 60% of the mean area of d6-NDMA in the standard solutions; and recovery in the spiked sample solution has to be between 70% and 130%.", "sentences": [], "annotations": [], "relations": []}, {"offset": 28055, "infons": {"section_type": "CONCL", "type": "title_1"}, "text": "5. Conclusions", "sentences": [], "annotations": [], "relations": []}, {"offset": 28070, "infons": {"section_type": "CONCL", "type": "paragraph"}, "text": "After the discovery of the presence of NAs in sartans and ranitidine (especially NDMA and NDEA), the metformin finished products are other medications that have been found to be contaminated with NDMA. After the sartans and ranitidine event, the scientists should have been more prepared for this type of crisis. However, the reality seems to be as brutal as always. Resolving the unexpected events in the case of sartans and ranitidine was achieved by withdrawing the finished product from the market.